Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy.
Prostatitis causes substantial morbidity to men, through associated urinary symptoms, sexual dysfunction, and pelvic pain; however, 90% to 95% of cases have an unknown etiology. Inflammation is associated with the development of carcinoma, and, therefore, it is imperative to identify and study the causes of prostatitis to improve our understanding of this disease and its role in prostate cancer. As estrogens cause prostatic inflammation, here we characterize the murine prostatic phenotype induced by elevated endogenous estrogens due to aromatase overexpression (AROM+). Early-life development of the AROM+ prostate was normal; however, progressive changes culminated in chronic inflammation and pre-malignancy. The AROM+ prostate was smaller at puberty compared with wild-type controls. Mast cell numbers were significantly increased at puberty and preceded chronic inflammation, which emerged by 40 weeks of age and was characterized by increased mast cell, macrophage, neutrophil, and T-lymphocyte numbers. The expression of key inflammatory mediators was also significantly altered, and premalignant prostatic intraepithelial neoplasia lesions emerged by 52 weeks of age. Taken together, these data link estrogens to prostatitis and premalignancy in the prostate, further implicating a role for estrogen in prostate cancer. These data also establish the AROM+ mouse as a novel, non-bacterial model for the study of prostatitis.
Ellem
Stuart J
SJ
Centre for Urological Research, Monash Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, Victoria 3168, Australia. Stuart.Ellem@med.monash.edu.au
Wang
Hong
H
Poutanen
Matti
M
Risbridger
Gail P
GP
D000367:Age Factors; D000818:Animals; D001141:Aromatase / Q000096:biosynthesis* / Q000235:genetics; D002908:Chronic Disease; D004195:Disease Models, Animal; D004967:Estrogens / Q000096:biosynthesis*; D006801:Humans; D007249:Inflammation; D008297:Male; D008407:Mast Cells / Q000276:immunology / Q000473:pathology; D051379:Mice; D016513:Mice, SCID; D008822:Mice, Transgenic; D011230:Precancerous Conditions / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D019048:Prostatic Intraepithelial Neoplasia / Q000209:etiology / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000209:etiology / Q000378:metabolism; D011472:Prostatitis / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D015854:Up-Regulation
D004967:Estrogens; D001141:Aromatase
J Urol. 1988 Nov;140(5):1049-53
3172358
Ann N Y Acad Sci. 2006 Nov;1089:1-13
17261752
Muscle Nerve. 2008 Jun;37(6):754-63
18506708
Dev Biol. 2001 Jan 15;229(2):432-42
11150243
Prostate Cancer Prostatic Dis. 2007;10(1):15-29
17199136
J Appl Physiol (1985). 2007 Jul;103(1):97-104
17395758
Endocrinology. 2006 Mar;147(3):1271-7
16306085
J Urol. 2002 Feb;167(2 Pt 1):753-6
11792966
Pathol Res Pract. 2002;198(4):267-71
12049335
Blood. 2003 Jan 1;101(1):210-5
12393677
Br J Cancer. 2007 Oct 8;97(7):952-6
17848955
Prostate. 2006 Feb 1;66(2):124-34
16161154
Prostate. 2007 Jun 1;67(8):888-99
17440979
Endocrinology. 2007 Feb;148(2):566-74
17068134
Dev Biol. 2001 Sep 1;237(1):145-58
11518512
Prostate. 1991;18(2):117-29
2006118
J Urol. 1998 Apr;159(4):1224-8
9507840
J Cancer Res Clin Oncol. 2008 Nov;134(11):1181-9
18465142
Prostate. 2000 Jun 15;44(1):19-25
10861753
Carcinogenesis. 2005 Jul;26(7):1170-81
15498784
J Urol. 2002 Jul;168(1):298-302
12050560
Gastroenterology. 1996 May;110(5):1482-90
8613053
Cancer Res. 2004 Mar 15;64(6):2270-305
15026373
Am J Pathol. 2006 Jun;168(6):1869-78
16723702
Br J Pharmacol. 2005 Aug;145(8):1062-8
15937521
J Pathol. 2005 May;206(1):52-61
15772937
J Biol Chem. 1997 Feb 28;272(9):5846-53
9038201
Cancer Res. 2001 Aug 15;61(16):6089-97
11507058
Br J Urol. 1982 Dec;54(6):729-31
7150931
Lancet. 2001 Feb 17;357(9255):539-45
11229684
J Cell Biochem. 2007 Jun 1;101(3):676-85
17216598
Development. 1991 Jan;111(1):145-58
2015790
J Intern Med. 2000 Sep;248(3):171-83
10971784
Prog Clin Biol Res. 1987;239:251-72
3309957
Epidemiology. 2002 Jan;13(1):72-9
11805589
Nature. 2002 Dec 19-26;420(6917):860-7
12490959
Mol Immunol. 2007 Mar;44(8):1977-85
17084457
Endocrinology. 2001 Jun;142(6):2458-67
11356695
FASEB J. 2008 May;22(5):1512-20
18055862
J Biol Chem. 2002 Nov 15;277(46):44475-84
12191999
Methods. 2001 Dec;25(4):402-8
11846609
Epidemiol Rev. 2001;23(1):144-51
11588840
J Clin Endocrinol Metab. 2004 May;89(5):2434-41
15126575
Cancer Res. 1991 Jul 1;51(13):3445-50
1711411
Prostate. 2007 Jan 1;67(1):14-21
17075821
J Urol. 1999 Aug;162(2):369-75
10411041
Med Hypotheses. 1984 May;14(1):29-39
6748989
J Infect Dis. 2007 Nov 1;196(9):1361-8
17922401
Endocrinology. 2002 Dec;143(12):4922-33
12446620
Gastroenterology. 1996 May;110(5):1656-8
8613078
Am J Pathol. 1999 Dec;155(6):1985-92
10595928
Reprod Toxicol. 1999 Nov-Dec;13(6):463-72
10613394
J Immunol. 2006 Feb 15;176(4):2238-48
16455980
Endocrinology. 2001 Jun;142(6):2435-42
11356692